High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial

27

Citations

24

References

2024

Year

Jiayi Yu, Leilei Jiang, Lina Zhao, Xue Yang, Xiaomin Wang, Dan Yang, Minglei Zhuo, Hanxiao Chen, Wei Huang, Zhengfei Zhu,

The Lancet Respiratory Medicine

Adaptive RadiotherapyStandard-dose RadiotherapyOncologyRadiation TherapyMedicineRadiation OncologyLung Cancer

References

	Year	Citations

Page 1